Signals of Venous Thromboembolism Risk from Drug–Drug Interactions Involving Benzodiazepines and Other Sedative Hypnotics: Self-Controlled Case Series Analyses

Clinical Drug Investigation · Published 2026-07-29 · DOI 10.1007/s40261-026-01582-8

Free full text

Authors (12)

Fengge Wang, Lin-Chieh Meng, Kacie Bogar, Colleen M. Brensinger, Warren B. Bilker, Sascha Dublin, Todd E. H. Hecht, John R. Horn, Daniela C. Moga, Michael E. Thase, Brian L. VanderBeek, Charles E. Leonard

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, F., Meng, L., Bogar, K., et al. (2026). Signals of Venous Thromboembolism Risk from Drug–Drug Interactions Involving Benzodiazepines and Other Sedative Hypnotics: Self-Controlled Case Series Analyses. Clinical Drug Investigation. https://doi.org/10.1007/s40261-026-01582-8

Related articles

• A pharmacoepidemiological nested case-control study of risk factors for venous thromboembolism with the focus on diabetes, cancer, socioeconomic group, medications, and comorbidities · Diabetes & Vascular Disease Research · 2024 · Cites or is cited by this article
• Effectiveness and Tolerability of Vortioxetine in Major Depressive Disorder: A Real-World Study in Switzerland · Clinical Drug Investigation · 2026 · Same journal
• Clinical Benefit of Multiple Myeloma Drugs at Regulatory Approval in Brazil, Europe, and the USA: A Retrospective Cohort Study (2003–2024) · Clinical Drug Investigation · 2026 · Same journal
• Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles · Clinical Drug Investigation · 2026 · Same journal
• Determinants and Prognostic Impact of In-Hospital Sodium-Glucose Cotransporter-2 Inhibitor Initiation in Patients with Heart Failure · Clinical Drug Investigation · 2026 · Same journal
• Missed Opportunities in the Therapeutic Patterns of Chronic Obstructive Pulmonary Disease: A Real-World Italian Study on the Impact of Severe Exacerbation on Mortality and Hospital Re-admission · Clinical Drug Investigation · 2026 · Same journal
• Milsaperidone: First Approval · Clinical Drug Investigation · 2026 · Same journal
• Cost-Consequences Analysis of Biologic Treatments for Moderate-to-Severe Crohn’s Disease Using Real-World Transition Probability and Cost Data in Thailand · Clinical Drug Investigation · 2026 · Same journal
• Amyloid-Related Imaging Abnormalities in Anti-amyloid Therapy: Clinical Implications of Kinetics for Safer Use and Risk Stratification · Clinical Drug Investigation · 2026 · Same journal
• Over-the-Counter Product Use Among Individuals with Vitiligo: A Cross-Sectional International Survey · Clinical Drug Investigation · 2026 · Same journal